Histopathological assessment of acetaminophen-induced liver injury and regeneration response following edible bird’s nest administration in ICR and BALB/C mice model
Acetaminophen (APAP) overdose is known to induce liver injury in mice models and humans. Excessive accumulation of reactive metabolite, N-acetyl-p-benzoquinone-imine (NAPQI) increases oxidative stress in tissues, leading to centrilobular necrosis after exceeding the glutathione (GSH) threshold....
Saved in:
Main Author: | |
---|---|
Format: | Thesis |
Language: | English |
Published: |
2021
|
Subjects: | |
Online Access: | http://psasir.upm.edu.my/id/eprint/97877/1/FPV%202021%2017%20UPMIR.pdf http://psasir.upm.edu.my/id/eprint/97877/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Universiti Putra Malaysia |
Language: | English |
Summary: | Acetaminophen (APAP) overdose is known to induce liver injury in mice models and
humans. Excessive accumulation of reactive metabolite, N-acetyl-p-benzoquinone-imine (NAPQI) increases oxidative stress in tissues, leading to centrilobular necrosis
after exceeding the glutathione (GSH) threshold. Although liver recovery takes place
after clearance of toxic insults, however, the degree of hepatic regeneration differs
between mice strains. Therefore, the first aim of the study was a comparative assessment
of APAP-induced liver injury (AILI) and subsequent hepatic regeneration of two mouse
models (ICR and BALB/c). Meanwhile, edible bird’s nest (EBN) is a well-known natural
product with various health-enhancing properties including anti-oxidative and cell
proliferative effects. However, the role of EBN from a toxicological perspective against
APAP toxicity is lacking. Hence, the second objective aimed to assess the prophylactic
and regenerative effect of EBN on AILI response in ICR mice. These studies
hypothesized that both models respond differently, and self-regenerating hepatocytes
could be prompted by prophylaxis EBN. For the first objective, 25 ICR and 20 BALB/c
mice were grouped as controls and treatments of 5, 10, 24, and 48 hours post-APAP
dosing (hpd) with 5 animals per each. Secondly, 80 ICR mice were assigned to groups
of control, APAP (500 mg/kg) and seven days prophylactic of silymarin (200 mg/kg),
and EBN (60, 120, and 250 mg/kg) followed by an APAP induction. Livers were
harvested for histopathological assessment by haematoxylin and eosin (H&E) staining
and proliferating cell nuclear antigen (PCNA) using immunohistochemistry. Results of
the first experiment showed that APAP-treated BALB/c mice had an intense
hepatocellular injury at 5 hpd than ICR mice that only exhibited damage at 10 hpd before
both underwent almost complete regeneration after 24 hpd. The second study revealed
significant differences in histological changes between APAP and prophylactic treatment
groups at 10 hpd, with complete recovery of all groups observed at 24 hpd except for
EBN 250 that sustained injuries. Hepatocytes proliferation was initiated at 5 hpd in
silymarin, EBN 60 and EBN 120, while at 24 hpd, EBN 120 and 250 exhibited higher
PCNA expressing hepatocytes. The hepatoprotective role was observed earlier in
silymarin, EBN 60 and 120, while cellular proliferation was delayed in EBN 250. In conclusion, all groups showed liver recovery after clearance of APAP insult at later time
points but EBN 60 and 120 enhanced the hepatic proliferation as similar to silymarin.
Therefore, this proves EBN 60 and 120 could act as prophylaxis liver supplements to
accelerate the hepatic regeneration in AILI. |
---|